These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35909048)

  • 1. Circulating de novo lipogenesis fatty acids and all-cause mortality in a prospective Dutch population cohort.
    Zhu Y; Vogelpohl FA; Heiner-Fokkema MR; Pranger IG; Minović I; Navis GJ; Bakker SJL; Riphagen IJ
    J Clin Lipidol; 2022; 16(5):658-666. PubMed ID: 35909048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study.
    Ma W; Wu JH; Wang Q; Lemaitre RN; Mukamal KJ; Djoussé L; King IB; Song X; Biggs ML; Delaney JA; Kizer JR; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2015 Jan; 101(1):153-63. PubMed ID: 25527759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway and Total Mortality, Cause-Specific Mortality, and Cardiovascular Diseases in the Cardiovascular Health Study.
    Lai HTM; de Oliveira Otto MC; Lee Y; Wu JHY; Song X; King IB; Psaty BM; Lemaitre RN; McKnight B; Siscovick DS; Mozaffarian D
    J Am Heart Assoc; 2019 Nov; 8(22):e012881. PubMed ID: 31711385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.
    Imamura F; Fretts AM; Marklund M; Ardisson Korat AV; Yang WS; Lankinen M; Qureshi W; Helmer C; Chen TA; Virtanen JK; Wong K; Bassett JK; Murphy R; Tintle N; Yu CI; Brouwer IA; Chien KL; Chen YY; Wood AC; Del Gobbo LC; Djousse L; Geleijnse JM; Giles GG; de Goede J; Gudnason V; Harris WS; Hodge A; Hu F; ; Koulman A; Laakso M; Lind L; Lin HJ; McKnight B; Rajaobelina K; Riserus U; Robinson JG; Samieri C; Senn M; Siscovick DS; Soedamah-Muthu SS; Sotoodehnia N; Sun Q; Tsai MY; Tuomainen TP; Uusitupa M; Wagenknecht LE; Wareham NJ; Wu JHY; Micha R; Lemaitre RN; Mozaffarian D; Forouhi NG
    PLoS Med; 2020 Jun; 17(6):e1003102. PubMed ID: 32530938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of diabetes associated with fatty acids in the de novo lipogenesis pathway is independent of insulin sensitivity and response: the Insulin Resistance Atherosclerosis Study (IRAS).
    Qureshi W; Santaren ID; Hanley AJ; Watkins SM; Lorenzo C; Wagenknecht LE
    BMJ Open Diabetes Res Care; 2019; 7(1):e000691. PubMed ID: 31543975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers.
    Rosqvist F; McNeil CA; Pramfalk C; Parry SA; Low WS; Cornfield T; Fielding BA; Hodson L
    Am J Clin Nutr; 2019 Feb; 109(2):260-268. PubMed ID: 30721918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial Biomarkers of De Novo Lipogenesis Fatty Acids and Incident Heart Failure in Older Adults: The Cardiovascular Health Study.
    Lee Y; Lai HTM; de Oliveira Otto MC; Lemaitre RN; McKnight B; King IB; Song X; Huggins GS; Vest AR; Siscovick DS; Mozaffarian D
    J Am Heart Assoc; 2020 Feb; 9(4):e014119. PubMed ID: 32020839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese.
    Zong G; Zhu J; Sun L; Ye X; Lu L; Jin Q; Zheng H; Yu Z; Zhu Z; Li H; Sun Q; Lin X
    Am J Clin Nutr; 2013 Aug; 98(2):319-26. PubMed ID: 23803879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study.
    Wu JH; Lemaitre RN; Imamura F; King IB; Song X; Spiegelman D; Siscovick DS; Mozaffarian D
    Am J Clin Nutr; 2011 Aug; 94(2):431-8. PubMed ID: 21697077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between erythrocyte fatty acids in de novo lipogenesis pathway and DXA-derived body fat and trunk fat distribution in Chinese adults: a prospective study.
    Zeng FF; Chen ZY; Zheng JS; Lin JS; Li YH; Qiu R; Wang C; Sun LL; Chen YM
    Eur J Nutr; 2019 Dec; 58(8):3229-3239. PubMed ID: 30470880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients.
    Bock M; von Schacky C; Scherr J; Lorenz E; Lechner B; Krannich A; Wachter R; Duvinage A; Edelmann F; Lechner K
    J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial.
    Costabile G; Della Pepa G; Salamone D; Luongo D; Naviglio D; Brancato V; Cavaliere C; Salvatore M; Cipriano P; Vitale M; Corrado A; Rivellese AA; Annuzzi G; Bozzetto L
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
    Wu JH; Lemaitre RN; Manichaikul A; Guan W; Tanaka T; Foy M; Kabagambe EK; Djousse L; Siscovick D; Fretts AM; Johnson C; King IB; Psaty BM; McKnight B; Rich SS; Chen YD; Nettleton JA; Tang W; Bandinelli S; Jacobs DR; Browning BL; Laurie CC; Gu X; Tsai MY; Steffen LM; Ferrucci L; Fornage M; Mozaffarian D
    Circ Cardiovasc Genet; 2013 Apr; 6(2):171-83. PubMed ID: 23362303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplemental palmitoleic (C16:1 cis-9) acid reduces lipogenesis and desaturation in bovine adipocyte cultures.
    Burns TA; Duckett SK; Pratt SL; Jenkins TC
    J Anim Sci; 2012 Oct; 90(10):3433-41. PubMed ID: 22851248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
    Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32188593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Supplemented Mediterranean Diets on Plasma-Phospholipid Fatty Acid Profiles and Risk of Cardiovascular Disease after 1 Year of Intervention in the PREDIMED Trial.
    Razquin C; Ruiz-Canela M; Wernitz A; Toledo E; Corella D; Alonso-Gómez Á; Fitó M; Gómez-Gracia E; Estruch R; Fiol M; Lapetra J; Serra-Majem L; Ros E; Arós F; Salas-Salvadó J; Schulze MB; Martinez-Gonzalez MA
    Clin Chem; 2023 Mar; 69(3):283-294. PubMed ID: 36683466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dietary and plasma phospholipid fatty acids between normal weight and overweight black South Africans according to metabolic health: The PURE study.
    Ojwang AA; Smuts CM; Zec M; Wentzel-Viljoen E; Kruger IM; Kruger HS
    Prostaglandins Leukot Essent Fatty Acids; 2020 Jul; 158():102039. PubMed ID: 31780327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between de novo lipogenesis susceptibility genes and coronary artery disease.
    Simons PIHG; Valkenburg O; Stehouwer CDA; Brouwers MCGJ
    Nutr Metab Cardiovasc Dis; 2022 Dec; 32(12):2883-2889. PubMed ID: 36182335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotope Labeling and Biochemical Assessment of Liver-Triacylglycerol in Patients with Different Levels of Histologically-Graded Liver Disease.
    Syed-Abdul MM; Moore MP; Wheeler AA; Ganga RR; Diaz-Arias A; Petroski GF; Rector RS; Ibdah JA; Parks EJ
    J Nutr; 2023 Dec; 153(12):3418-3429. PubMed ID: 37774841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States.
    Diffenderfer MR; Rajapakse N; Pham E; He L; Dansinger ML; Nelson JR; Schaefer EJ
    J Clin Lipidol; 2022; 16(2):184-197. PubMed ID: 35120898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.